1887

Abstract

A routine protocol for diagnosing -associated diarrhoea (CDAD) based on both faecal-cytotoxin detection and toxigenic culture was adopted by the microbiology laboratory of the St Luc-UCL University Hospital in Brussels in 1997. A toxigenic culture is a faecal culture followed, in the case of positivity, by a direct immunoassay on colonies to detect toxin A production. The results obtained over the past 7 years in the hospital are reviewed here. A total of 10 552 diarrhoeal stools from 7042 patients were analysed, of which 9494 were negative for all tests. A total of 1058 samples (10 %) from 794 patients were culture-positive, of which 460 (4.4 %) were positive for a faecal cytotoxin. The remaining 598 cultures were tested for toxin A on colonies; 355 of them were positive, which is 3.4 % of the total, and the remaining 243 (2.3 %) were negative. The positivity of the faecal-cytotoxin assay was statistically linked to the number of colonies observed on the culture plate. In conclusion, over a 7 year period, toxigenic culture allowed the diagnosis of 355 cases of CDAD that would have been missed by a protocol using a faecal-cytotoxin assay alone. In terms of both patient care, prevention of environmental contamination and prevention of risk of a hospital outbreak, it is proposed that these results justify the recommendation to perform both faecal-toxin assay and culture in routine medical practice.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.45844-0
2005-02-01
2019-11-19
Loading full text...

Full text loading...

/deliver/fulltext/jmm/54/2/JM540215.html?itemId=/content/journal/jmm/10.1099/jmm.0.45844-0&mimeType=html&fmt=ahah

References

  1. Alfa, M. J., Kabani, A., Lyerly, D. & 7 other authors ( 2000;). Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea. J Clin Microbiol 38, 2706–2714.
    [Google Scholar]
  2. Barbut, F., Kajzer, C., Planas, N. & Petit, J. C. ( 1993;). Comparison of three enzyme immunoassays, a cytotoxicity assay, and toxigenic culture for diagnosis of Clostridium difficile-associated diarrhea. J Clin Microbiol 31, 963–967.
    [Google Scholar]
  3. Barbut, F., Lalande, V., Burghoffer, B., Thien, H. V., Grimprel, E. & Petit, J. C. ( 2002;). Prevalence and genetic characterization of toxin A variant strains of Clostridium difficile among adults and children with diarrhea in France. J Clin Microbiol 40, 2079–2083.[CrossRef]
    [Google Scholar]
  4. Barbut, F., Corthier, G., Charpak, Y. & 14 other authors ( 1996;). Prevalence and pathogenicity of Clostridium difficile in hospitalized patients.A French multicenter study. Arch Intern Med 156, 1449–1454.[CrossRef]
    [Google Scholar]
  5. Barbut, F., Delmée, M., Brazier, J. S. & 9 other authors ( 2003;). A European survey of diagnostic methods and testing protocols for Clostridium difficile. Clin Microbiol Infect 9, 989–996.[CrossRef]
    [Google Scholar]
  6. Barbut, F., Decré, D., Burghoffer, B. & 8 other authors ( 1999;). Antimicrobial susceptibilities and serogroups of clinical strains of Clostridium difficile isolated in France in 1991 and 1997. Antimicrob Agents Chemother 43, 2607–2611.
    [Google Scholar]
  7. Bartlett, J. G. ( 2002;). Clinical practice.Antibiotic-associated diarrhea. N Engl J Med 346, 334–339.[CrossRef]
    [Google Scholar]
  8. Berrington, A., Borriello, S. P., Brazier, J. S. & 9 other authors ( 2004;). National Clostridium difficile Standards Group: report to the Department of Health. J Hosp Infect 56 Suppl 1, 1–38.
    [Google Scholar]
  9. Brazier, J. S. ( 1998;). The diagnosis of Clostridium difficile-associated disease. J Antimicrob Chemother 41 Suppl C, 29–40.
    [Google Scholar]
  10. Brazier, J. S. ( 2001;). Typing of Clostridium difficile. Clin Microbiol Infect 7, 428–431.[CrossRef]
    [Google Scholar]
  11. Delmée, M. ( 2001;). Laboratory diagnosis of Clostridium difficile disease. Clin Microbiol Infect 7, 411–416.[CrossRef]
    [Google Scholar]
  12. Delmée, M., Vandercam, B., Avesani, V. & Michaux, J. L. ( 1987;). Epidemiology and prevention of Clostridium difficile infections in a leukaemia unit. Eur J Clin Microbiol 6, 623–627.[CrossRef]
    [Google Scholar]
  13. Fedorko, D. P., Engler, H. D., O'Shaughnessy, E. M., Williams, E. C., Reichelderfer, C. J., Smith, W. I., Jr ( 1999;). Evaluation of two rapid assays for detection of Clostridium difficile toxin A in stool specimens. J Clin Microbiol 37, 3044–3047.
    [Google Scholar]
  14. George, W. L., Sutter, V. L., Citron, D. & Finegold, S. M. ( 1979;). Selective and differential medium for isolation of Clostridium difficile. J Clin Microbiol 9, 214–219.
    [Google Scholar]
  15. Kelly, C. P. & LaMont, J. T. ( 1998;). Clostridium difficile infection. Annu Rev Med 49, 375–390.[CrossRef]
    [Google Scholar]
  16. Kuijper, E. J., de Weerdt, J., Kato, H., Kato, N., van Dam, A. P., van der Vorm, E. R., Weel, J., van Rheenen, C. & Dankert, J. ( 2001;). Nosocomial outbreak of Clostridium difficile-associated diarrhoea due to a clindamycin-resistant enterotoxin A-negative strain. Eur J Clin Microbiol Infect Dis 20, 528–534.[CrossRef]
    [Google Scholar]
  17. Kyne, L., Sougioultzis, S., McFarland, L. V. & Kelly, C. P. ( 2002a;). Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect Control Hosp Epidemiol 23, 653–659.[CrossRef]
    [Google Scholar]
  18. Kyne, L., Hamel, M. B., Polavaram, R. & Kelly, C. P. ( 2002b;). Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 34, 346–353.[CrossRef]
    [Google Scholar]
  19. Lozniewski, A., Rabaud, C., Dotto, E., Weber, M. & Mory, F. ( 2001;). Laboratory diagnosis of Clostridium difficile-associated diarrhea and colitis: usefulness of Premier Cytoclone A+B enzyme immunoassay for combined detection of stool toxins and toxigenic C.difficile strains. J Clin Microbiol 39, 1996–1998.[CrossRef]
    [Google Scholar]
  20. Mulligan, M. E., Rolfe, R. D., Finegold, S. M. & George, W. L. ( 1979;). Contamination of a hospital environment by Clostridium difficile. Curr Microbiol 3, 173–175.[CrossRef]
    [Google Scholar]
  21. Pelaez, T., Alcala, L., Alonso, R., Rodriguez-Creixems, M., Garcia-Lechuz, J. M. & Bouza, E. ( 2002;). Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin. Antimicrob Agents Chemother 46, 1647–1650.[CrossRef]
    [Google Scholar]
  22. Samra, Z., Talmor, S. & Bahar, J. ( 2002;). High prevalence of toxin A-negative toxin B-positive Clostridium difficile in hospitalized patients with gastrointestinal disease. Diagn Microbiol Infect Dis 43, 189–192.[CrossRef]
    [Google Scholar]
  23. Thonnard, J., Carreer, F., Avesani, V. & Delmée, M. ( 1996;). Toxin A detection on Clostridium difficile colonies from 24-h cultures. Clin Microbiol Infect 2, 50–54.[CrossRef]
    [Google Scholar]
  24. Wilcox, M. H., Cunniffe, J. G., Trundle, C. & Redpath, C. ( 1996;). Financial burden of hospital-acquired Clostridium difficile infection. J Hosp Infect 34, 23–30.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.45844-0
Loading
/content/journal/jmm/10.1099/jmm.0.45844-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error